Transcend Capital Advisors, LLC Reata Pharmaceuticals Inc Transaction History

Transcend Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	BUY	$30.85 - $93.17 $92,550 - $279,510	3,000 New	3,000 $272,000
Q4 2021 Jan 20, 2022	SELL	$25.61 - $110.96 $128,050 - $554,800	-5,000 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$100.0 - $143.02 $500,000 - $715,100	5,000 New	5,000 $485,000
Q2 2021 Aug 13, 2021	SELL	$78.27 - $151.29 $442,225 - $854,788	-5,650 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$94.25 - $132.81 $23,562 - $33,202	250 Added 4.63%	5,650 $564,000
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $550,962 - $996,948	5,400 New	5,400 $668,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Transcend Capital Advisors, LLC with notifications on news.